ABUS
Arbutus Biopharma Corp
4.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.3% | 91.4% | 90.4% | 92.6% | 94.5% | 96.7% | 99.8% | 99.9% | 99.7% | 99.8% | 99.9% | 99.9% | |
| 11.1% | 18.2% | 28.7% | 39.2% | 22.7% | 27.6% | 31.7% | 36.2% | 22.9% | 19.0% | 8.6% | 7.0% | |
| 84.6% | 87.3% | 86.0% | 88.7% | 91.0% | 93.1% | 96.3% | 95.0% | 95.9% | 96.7% | 34.4% | 33.8% | |
| 1.7% | 1.2% | 1.4% | 1.3% | 1.1% | 1.8% | 1.0% | 1.0% | 0.9% | 1.8% | 0.5% | 65.6% | |
| -3.3% | – | 0.0% | -3.9% | – | – | – | – | – | – | – | – | |
| 24.8% | 26.6% | 23.7% | 23.5% | 23.9% | 26.1% | 32.4% | 19.6% | 20.8% | 19.1% | 6.1% | 5.6% | |
| 14.1% | 15.6% | 13.5% | 14.1% | 13.5% | 11.9% | 16.6% | 4.9% | 5.3% | 6.3% | 1.8% | 1.2% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% | 0.5% | 0.5% | 0.6% | 0.2% | 0.2% | |
| 1.4% | 2.2% | 2.5% | 1.7% | 1.6% | 1.8% | 1.9% | 1.3% | 1.0% | 1.2% | 0.5% | 1.0% | |
| 75.2% | 73.4% | 76.3% | 76.5% | 76.1% | 73.9% | 67.6% | 80.4% | 79.2% | 80.9% | 93.9% | 94.4% | |
| -792.6% | -884.1% | -861.4% | -821.2% | -949.9% | -1,022.4% | -1,171.8% | -1,325.3% | -1,408.6% | -1,458.6% | -436.7% | -443.6% | |
| 105.6% | 116.6% | 116.9% | 117.5% | 134.6% | 144.2% | 163.0% | 186.3% | 196.3% | 202.5% | 70.4% | 72.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.